A whistleblower lawsuit against Abbott Laboratories was given the green light to continue in federal court, surging Abbott’s motion to dismiss in the Eastern District of Pennsylvania.
According to the lawsuit, which was brought under the qui tam provisions of the False Claims Act in 2009 by former Abbott sales representative Amy Bergman,
On Thursday, January 30, 2014, a whistleblower lawsuit alleging that Northrop Grumman defrauded the Department of Homeland Security (“DHS”) was unsealed in federal Court. According to the suit, which was filed under the qui tam provisions of the False Claims Act by former Northrop Grumman employee Leo Danilides, Northrop Grumman violated the terms of a DHS missile-defense contract for commercial airlines under the Counter-MANPADS program.
Langhorne-based St. Mary Medical Center has agreed to pay the federal government more than $2.3 million to resolve allegations that it overpaid doctors who referred patients to the hospital.
The 15 doctors who received the overpayments referred patients covered by Medicare and Medicaid, according to the government,
The Department of Justice raked in more than $8 billion in fiscal year 2013, scoring big on a variety of civil and criminal enforcement actions.
Almost $6 billion came from civil actions, with $3.2 billion related to health-care fraud. Big hauls included $800 million from a settlement with Abbott Laboratories and about $750 million from a settlement with Amgen.
With due respect to our friends at the Internal Revenue Service, most people would rather not hear from them this year. (Well, unless they have a hankering to discuss “Party of Five” with an IRS agent. But we digress.)
But we’re guessing the whistleblower who recently received $20 million for a tip he gave the IRS in 2006 feels differently.
The Centers for Medicare & Medicaid Services released a proposed rule this week that could allow Medicare Part D plans to curtail coverage for antidepressants.
The rule would remove antidepressants and immunosuppressants from so-called “protected” status in 2015 and would potentially ax antipsychotics from the list a year later.
New York City will pay the federal government more than $1 million to settle a whistleblower claim alleging fraud by the city’s schools.
The $1.375-million settlement, announced Monday, resolves allegations that the New York Education Department submitted false claims for Medicaid services not provided to special-education students.
For the full press release, please see:
http://www.justice.gov/opa/pr/2014/January/14-civ-037.html
Allergan Inc. paid kickbacks to induce prescriptions of the pharmaceutical company’s eye care drugs, according to allegations raised in a lawsuit unsealed on December 17, 2013 in federal court in Philadelphia. The lawsuit alleges that Allergan provided illegal inducements to eye care professionals throughout the United States, including business consulting services through its team of Eye Care Business Advisors,
On December 30, 2013, the United States District Court for the Western District of North Carolina, in response to a Department of Justice motion, unsealed a whistleblower lawsuit filed by North Carolina Emergency Room Physicians against Health Management Associates and Emergency Medical Services Corporation (“EmCare”). The “qui tam” whistleblower lawsuit was filed in Charlotte,
If you are aware of any person, corporation or entity that you think may be violating the Federal False Claims Act or a State False Claims Act, contact us today.